Global Animal Vaccine Market

Animal Vaccine Comprehensive Study by Type (Live attenuated vaccines, Inactivated vaccines, Toxoid vaccines, Recombinant vaccines, Other vaccines.), Application (Porcine, Poultry, Livestock, Companion Animals, Aquaculture) Players and Region - Global Market Outlook to 2026

Animal Vaccine Market by XX Submarkets | Forecast Years 2022-2027  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
What is Animal VaccineMarket?
Animal vaccines are medicines that are used to prevent and cure animal diseases. Animal vaccines are controlled by the US Department of Agriculture and they gives the result whether these vaccines are safe for animals or not. Increment in count of animal lovers and key players are involved in launching new products and more beneficial products, will fuel the growth of the animal vaccine market. World Society for the Protection of Animals, Animal Health Institute, American Pet Products Association, World Organization for Animal Health, Department of Livestock Development, Ministry of Agriculture and Cooperatives, Federation of Asian Veterinary Associations, and Thai Veterinary Medical Association are the regulatory bodies working for healthcare sector of animals.

Market Drivers
Increasing number of animal lovers and Livestock farming sector is increasing rapidly

Opportunities
Growing initiatives by government agencies and animal association and Increasing awareness in emerging countries

The Players Covered in the Study are:
Zoetis (United States), Merck Animal Health (United States), Elanco (United States), Boehringer Ingelheim (Germany), Ceva (France), Phibro Animal Health (United States), Virbac (France), Vetoquinol (France), Hester (India), Hipra (Spain), IDT Biologika (Germany), China Animal Husbandry (China), Biogenesis Bago (Argentina), Tianjin Ringpu (China) and Jinyu Bio-technology (China)



Report Objectives / Segmentation Covered

By Type
  • live attenuated vaccines
  • inactivated vaccines
  • toxoid vaccines
  • recombinant vaccines
  • other vaccines.
By Application
  • Porcine
  • Poultry
  • Livestock
  • Companion Animals
  • Aquaculture
By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increasing number of animal lovers
      • 3.2.2. Livestock farming sector is increasing rapidly
    • 3.3. Market Trends
      • 3.3.1. Continuously increasing product portfolio
      • 3.3.2. Increasing investments in manufacturing processes by key players
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Animal Vaccine, by Type, Application and Region (value) (2015-2020)
    • 5.1. Introduction
    • 5.2. Global Animal Vaccine (Value)
      • 5.2.1. Global Animal Vaccine by: Type (Value)
        • 5.2.1.1. Live attenuated vaccines
        • 5.2.1.2. Inactivated vaccines
        • 5.2.1.3. Toxoid vaccines
        • 5.2.1.4. Recombinant vaccines
        • 5.2.1.5. Other vaccines.
      • 5.2.2. Global Animal Vaccine by: Application (Value)
        • 5.2.2.1. Porcine
        • 5.2.2.2. Poultry
        • 5.2.2.3. Livestock
        • 5.2.2.4. Companion Animals
        • 5.2.2.5. Aquaculture
      • 5.2.3. Global Animal Vaccine Region
        • 5.2.3.1. South America
          • 5.2.3.1.1. Brazil
          • 5.2.3.1.2. Argentina
          • 5.2.3.1.3. Rest of South America
        • 5.2.3.2. Asia Pacific
          • 5.2.3.2.1. China
          • 5.2.3.2.2. Japan
          • 5.2.3.2.3. India
          • 5.2.3.2.4. South Korea
          • 5.2.3.2.5. Taiwan
          • 5.2.3.2.6. Australia
          • 5.2.3.2.7. Rest of Asia-Pacific
        • 5.2.3.3. Europe
          • 5.2.3.3.1. Germany
          • 5.2.3.3.2. France
          • 5.2.3.3.3. Italy
          • 5.2.3.3.4. United Kingdom
          • 5.2.3.3.5. Netherlands
          • 5.2.3.3.6. Rest of Europe
        • 5.2.3.4. MEA
          • 5.2.3.4.1. Middle East
          • 5.2.3.4.2. Africa
        • 5.2.3.5. North America
          • 5.2.3.5.1. United States
          • 5.2.3.5.2. Canada
          • 5.2.3.5.3. Mexico
  • 6. Animal Vaccine: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2020)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Zoetis (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Merck Animal Health (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Elanco (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Boehringer Ingelheim (Germany)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Ceva (France)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Phibro Animal Health (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Virbac (France)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Vetoquinol (France)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Hester (India)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Hipra (Spain)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
      • 6.4.11. IDT Biologika (Germany)
        • 6.4.11.1. Business Overview
        • 6.4.11.2. Products/Services Offerings
        • 6.4.11.3. Financial Analysis
        • 6.4.11.4. SWOT Analysis
      • 6.4.12. China Animal Husbandry (China)
        • 6.4.12.1. Business Overview
        • 6.4.12.2. Products/Services Offerings
        • 6.4.12.3. Financial Analysis
        • 6.4.12.4. SWOT Analysis
      • 6.4.13. Biogenesis Bago (Argentina)
        • 6.4.13.1. Business Overview
        • 6.4.13.2. Products/Services Offerings
        • 6.4.13.3. Financial Analysis
        • 6.4.13.4. SWOT Analysis
      • 6.4.14. Tianjin Ringpu (China)
        • 6.4.14.1. Business Overview
        • 6.4.14.2. Products/Services Offerings
        • 6.4.14.3. Financial Analysis
        • 6.4.14.4. SWOT Analysis
      • 6.4.15. Jinyu Bio-technology (China)
        • 6.4.15.1. Business Overview
        • 6.4.15.2. Products/Services Offerings
        • 6.4.15.3. Financial Analysis
        • 6.4.15.4. SWOT Analysis
  • 7. Global Animal Vaccine Sale, by Type, Application and Region (value) (2021-2026)
    • 7.1. Introduction
    • 7.2. Global Animal Vaccine (Value)
      • 7.2.1. Global Animal Vaccine by: Type (Value)
        • 7.2.1.1. Live attenuated vaccines
        • 7.2.1.2. Inactivated vaccines
        • 7.2.1.3. Toxoid vaccines
        • 7.2.1.4. Recombinant vaccines
        • 7.2.1.5. Other vaccines.
      • 7.2.2. Global Animal Vaccine by: Application (Value)
        • 7.2.2.1. Porcine
        • 7.2.2.2. Poultry
        • 7.2.2.3. Livestock
        • 7.2.2.4. Companion Animals
        • 7.2.2.5. Aquaculture
      • 7.2.3. Global Animal Vaccine Region
        • 7.2.3.1. South America
          • 7.2.3.1.1. Brazil
          • 7.2.3.1.2. Argentina
          • 7.2.3.1.3. Rest of South America
        • 7.2.3.2. Asia Pacific
          • 7.2.3.2.1. China
          • 7.2.3.2.2. Japan
          • 7.2.3.2.3. India
          • 7.2.3.2.4. South Korea
          • 7.2.3.2.5. Taiwan
          • 7.2.3.2.6. Australia
          • 7.2.3.2.7. Rest of Asia-Pacific
        • 7.2.3.3. Europe
          • 7.2.3.3.1. Germany
          • 7.2.3.3.2. France
          • 7.2.3.3.3. Italy
          • 7.2.3.3.4. United Kingdom
          • 7.2.3.3.5. Netherlands
          • 7.2.3.3.6. Rest of Europe
        • 7.2.3.4. MEA
          • 7.2.3.4.1. Middle East
          • 7.2.3.4.2. Africa
        • 7.2.3.5. North America
          • 7.2.3.5.1. United States
          • 7.2.3.5.2. Canada
          • 7.2.3.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Animal Vaccine: by Type(USD Million)
  • Table 2. Animal Vaccine Live attenuated vaccines , by Region USD Million (2015-2020)
  • Table 3. Animal Vaccine Inactivated vaccines , by Region USD Million (2015-2020)
  • Table 4. Animal Vaccine Toxoid vaccines , by Region USD Million (2015-2020)
  • Table 5. Animal Vaccine Recombinant vaccines , by Region USD Million (2015-2020)
  • Table 6. Animal Vaccine Other vaccines. , by Region USD Million (2015-2020)
  • Table 7. Animal Vaccine: by Application(USD Million)
  • Table 8. Animal Vaccine Porcine , by Region USD Million (2015-2020)
  • Table 9. Animal Vaccine Poultry , by Region USD Million (2015-2020)
  • Table 10. Animal Vaccine Livestock , by Region USD Million (2015-2020)
  • Table 11. Animal Vaccine Companion Animals , by Region USD Million (2015-2020)
  • Table 12. Animal Vaccine Aquaculture , by Region USD Million (2015-2020)
  • Table 13. South America Animal Vaccine, by Country USD Million (2015-2020)
  • Table 14. South America Animal Vaccine, by Type USD Million (2015-2020)
  • Table 15. South America Animal Vaccine, by Application USD Million (2015-2020)
  • Table 16. Brazil Animal Vaccine, by Type USD Million (2015-2020)
  • Table 17. Brazil Animal Vaccine, by Application USD Million (2015-2020)
  • Table 18. Argentina Animal Vaccine, by Type USD Million (2015-2020)
  • Table 19. Argentina Animal Vaccine, by Application USD Million (2015-2020)
  • Table 20. Rest of South America Animal Vaccine, by Type USD Million (2015-2020)
  • Table 21. Rest of South America Animal Vaccine, by Application USD Million (2015-2020)
  • Table 22. Asia Pacific Animal Vaccine, by Country USD Million (2015-2020)
  • Table 23. Asia Pacific Animal Vaccine, by Type USD Million (2015-2020)
  • Table 24. Asia Pacific Animal Vaccine, by Application USD Million (2015-2020)
  • Table 25. China Animal Vaccine, by Type USD Million (2015-2020)
  • Table 26. China Animal Vaccine, by Application USD Million (2015-2020)
  • Table 27. Japan Animal Vaccine, by Type USD Million (2015-2020)
  • Table 28. Japan Animal Vaccine, by Application USD Million (2015-2020)
  • Table 29. India Animal Vaccine, by Type USD Million (2015-2020)
  • Table 30. India Animal Vaccine, by Application USD Million (2015-2020)
  • Table 31. South Korea Animal Vaccine, by Type USD Million (2015-2020)
  • Table 32. South Korea Animal Vaccine, by Application USD Million (2015-2020)
  • Table 33. Taiwan Animal Vaccine, by Type USD Million (2015-2020)
  • Table 34. Taiwan Animal Vaccine, by Application USD Million (2015-2020)
  • Table 35. Australia Animal Vaccine, by Type USD Million (2015-2020)
  • Table 36. Australia Animal Vaccine, by Application USD Million (2015-2020)
  • Table 37. Rest of Asia-Pacific Animal Vaccine, by Type USD Million (2015-2020)
  • Table 38. Rest of Asia-Pacific Animal Vaccine, by Application USD Million (2015-2020)
  • Table 39. Europe Animal Vaccine, by Country USD Million (2015-2020)
  • Table 40. Europe Animal Vaccine, by Type USD Million (2015-2020)
  • Table 41. Europe Animal Vaccine, by Application USD Million (2015-2020)
  • Table 42. Germany Animal Vaccine, by Type USD Million (2015-2020)
  • Table 43. Germany Animal Vaccine, by Application USD Million (2015-2020)
  • Table 44. France Animal Vaccine, by Type USD Million (2015-2020)
  • Table 45. France Animal Vaccine, by Application USD Million (2015-2020)
  • Table 46. Italy Animal Vaccine, by Type USD Million (2015-2020)
  • Table 47. Italy Animal Vaccine, by Application USD Million (2015-2020)
  • Table 48. United Kingdom Animal Vaccine, by Type USD Million (2015-2020)
  • Table 49. United Kingdom Animal Vaccine, by Application USD Million (2015-2020)
  • Table 50. Netherlands Animal Vaccine, by Type USD Million (2015-2020)
  • Table 51. Netherlands Animal Vaccine, by Application USD Million (2015-2020)
  • Table 52. Rest of Europe Animal Vaccine, by Type USD Million (2015-2020)
  • Table 53. Rest of Europe Animal Vaccine, by Application USD Million (2015-2020)
  • Table 54. MEA Animal Vaccine, by Country USD Million (2015-2020)
  • Table 55. MEA Animal Vaccine, by Type USD Million (2015-2020)
  • Table 56. MEA Animal Vaccine, by Application USD Million (2015-2020)
  • Table 57. Middle East Animal Vaccine, by Type USD Million (2015-2020)
  • Table 58. Middle East Animal Vaccine, by Application USD Million (2015-2020)
  • Table 59. Africa Animal Vaccine, by Type USD Million (2015-2020)
  • Table 60. Africa Animal Vaccine, by Application USD Million (2015-2020)
  • Table 61. North America Animal Vaccine, by Country USD Million (2015-2020)
  • Table 62. North America Animal Vaccine, by Type USD Million (2015-2020)
  • Table 63. North America Animal Vaccine, by Application USD Million (2015-2020)
  • Table 64. United States Animal Vaccine, by Type USD Million (2015-2020)
  • Table 65. United States Animal Vaccine, by Application USD Million (2015-2020)
  • Table 66. Canada Animal Vaccine, by Type USD Million (2015-2020)
  • Table 67. Canada Animal Vaccine, by Application USD Million (2015-2020)
  • Table 68. Mexico Animal Vaccine, by Type USD Million (2015-2020)
  • Table 69. Mexico Animal Vaccine, by Application USD Million (2015-2020)
  • Table 70. Company Basic Information, Sales Area and Its Competitors
  • Table 71. Company Basic Information, Sales Area and Its Competitors
  • Table 72. Company Basic Information, Sales Area and Its Competitors
  • Table 73. Company Basic Information, Sales Area and Its Competitors
  • Table 74. Company Basic Information, Sales Area and Its Competitors
  • Table 75. Company Basic Information, Sales Area and Its Competitors
  • Table 76. Company Basic Information, Sales Area and Its Competitors
  • Table 77. Company Basic Information, Sales Area and Its Competitors
  • Table 78. Company Basic Information, Sales Area and Its Competitors
  • Table 79. Company Basic Information, Sales Area and Its Competitors
  • Table 80. Company Basic Information, Sales Area and Its Competitors
  • Table 81. Company Basic Information, Sales Area and Its Competitors
  • Table 82. Company Basic Information, Sales Area and Its Competitors
  • Table 83. Company Basic Information, Sales Area and Its Competitors
  • Table 84. Company Basic Information, Sales Area and Its Competitors
  • Table 85. Animal Vaccine: by Type(USD Million)
  • Table 86. Animal Vaccine Live attenuated vaccines , by Region USD Million (2021-2026)
  • Table 87. Animal Vaccine Inactivated vaccines , by Region USD Million (2021-2026)
  • Table 88. Animal Vaccine Toxoid vaccines , by Region USD Million (2021-2026)
  • Table 89. Animal Vaccine Recombinant vaccines , by Region USD Million (2021-2026)
  • Table 90. Animal Vaccine Other vaccines. , by Region USD Million (2021-2026)
  • Table 91. Animal Vaccine: by Application(USD Million)
  • Table 92. Animal Vaccine Porcine , by Region USD Million (2021-2026)
  • Table 93. Animal Vaccine Poultry , by Region USD Million (2021-2026)
  • Table 94. Animal Vaccine Livestock , by Region USD Million (2021-2026)
  • Table 95. Animal Vaccine Companion Animals , by Region USD Million (2021-2026)
  • Table 96. Animal Vaccine Aquaculture , by Region USD Million (2021-2026)
  • Table 97. South America Animal Vaccine, by Country USD Million (2021-2026)
  • Table 98. South America Animal Vaccine, by Type USD Million (2021-2026)
  • Table 99. South America Animal Vaccine, by Application USD Million (2021-2026)
  • Table 100. Brazil Animal Vaccine, by Type USD Million (2021-2026)
  • Table 101. Brazil Animal Vaccine, by Application USD Million (2021-2026)
  • Table 102. Argentina Animal Vaccine, by Type USD Million (2021-2026)
  • Table 103. Argentina Animal Vaccine, by Application USD Million (2021-2026)
  • Table 104. Rest of South America Animal Vaccine, by Type USD Million (2021-2026)
  • Table 105. Rest of South America Animal Vaccine, by Application USD Million (2021-2026)
  • Table 106. Asia Pacific Animal Vaccine, by Country USD Million (2021-2026)
  • Table 107. Asia Pacific Animal Vaccine, by Type USD Million (2021-2026)
  • Table 108. Asia Pacific Animal Vaccine, by Application USD Million (2021-2026)
  • Table 109. China Animal Vaccine, by Type USD Million (2021-2026)
  • Table 110. China Animal Vaccine, by Application USD Million (2021-2026)
  • Table 111. Japan Animal Vaccine, by Type USD Million (2021-2026)
  • Table 112. Japan Animal Vaccine, by Application USD Million (2021-2026)
  • Table 113. India Animal Vaccine, by Type USD Million (2021-2026)
  • Table 114. India Animal Vaccine, by Application USD Million (2021-2026)
  • Table 115. South Korea Animal Vaccine, by Type USD Million (2021-2026)
  • Table 116. South Korea Animal Vaccine, by Application USD Million (2021-2026)
  • Table 117. Taiwan Animal Vaccine, by Type USD Million (2021-2026)
  • Table 118. Taiwan Animal Vaccine, by Application USD Million (2021-2026)
  • Table 119. Australia Animal Vaccine, by Type USD Million (2021-2026)
  • Table 120. Australia Animal Vaccine, by Application USD Million (2021-2026)
  • Table 121. Rest of Asia-Pacific Animal Vaccine, by Type USD Million (2021-2026)
  • Table 122. Rest of Asia-Pacific Animal Vaccine, by Application USD Million (2021-2026)
  • Table 123. Europe Animal Vaccine, by Country USD Million (2021-2026)
  • Table 124. Europe Animal Vaccine, by Type USD Million (2021-2026)
  • Table 125. Europe Animal Vaccine, by Application USD Million (2021-2026)
  • Table 126. Germany Animal Vaccine, by Type USD Million (2021-2026)
  • Table 127. Germany Animal Vaccine, by Application USD Million (2021-2026)
  • Table 128. France Animal Vaccine, by Type USD Million (2021-2026)
  • Table 129. France Animal Vaccine, by Application USD Million (2021-2026)
  • Table 130. Italy Animal Vaccine, by Type USD Million (2021-2026)
  • Table 131. Italy Animal Vaccine, by Application USD Million (2021-2026)
  • Table 132. United Kingdom Animal Vaccine, by Type USD Million (2021-2026)
  • Table 133. United Kingdom Animal Vaccine, by Application USD Million (2021-2026)
  • Table 134. Netherlands Animal Vaccine, by Type USD Million (2021-2026)
  • Table 135. Netherlands Animal Vaccine, by Application USD Million (2021-2026)
  • Table 136. Rest of Europe Animal Vaccine, by Type USD Million (2021-2026)
  • Table 137. Rest of Europe Animal Vaccine, by Application USD Million (2021-2026)
  • Table 138. MEA Animal Vaccine, by Country USD Million (2021-2026)
  • Table 139. MEA Animal Vaccine, by Type USD Million (2021-2026)
  • Table 140. MEA Animal Vaccine, by Application USD Million (2021-2026)
  • Table 141. Middle East Animal Vaccine, by Type USD Million (2021-2026)
  • Table 142. Middle East Animal Vaccine, by Application USD Million (2021-2026)
  • Table 143. Africa Animal Vaccine, by Type USD Million (2021-2026)
  • Table 144. Africa Animal Vaccine, by Application USD Million (2021-2026)
  • Table 145. North America Animal Vaccine, by Country USD Million (2021-2026)
  • Table 146. North America Animal Vaccine, by Type USD Million (2021-2026)
  • Table 147. North America Animal Vaccine, by Application USD Million (2021-2026)
  • Table 148. United States Animal Vaccine, by Type USD Million (2021-2026)
  • Table 149. United States Animal Vaccine, by Application USD Million (2021-2026)
  • Table 150. Canada Animal Vaccine, by Type USD Million (2021-2026)
  • Table 151. Canada Animal Vaccine, by Application USD Million (2021-2026)
  • Table 152. Mexico Animal Vaccine, by Type USD Million (2021-2026)
  • Table 153. Mexico Animal Vaccine, by Application USD Million (2021-2026)
  • Table 154. Research Programs/Design for This Report
  • Table 155. Key Data Information from Secondary Sources
  • Table 156. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Animal Vaccine: by Type USD Million (2015-2020)
  • Figure 5. Global Animal Vaccine: by Application USD Million (2015-2020)
  • Figure 6. South America Animal Vaccine Share (%), by Country
  • Figure 7. Asia Pacific Animal Vaccine Share (%), by Country
  • Figure 8. Europe Animal Vaccine Share (%), by Country
  • Figure 9. MEA Animal Vaccine Share (%), by Country
  • Figure 10. North America Animal Vaccine Share (%), by Country
  • Figure 11. Global Animal Vaccine share by Players 2020 (%)
  • Figure 12. Global Animal Vaccine share by Players (Top 3) 2020(%)
  • Figure 13. Global Animal Vaccine share by Players (Top 5) 2020(%)
  • Figure 14. BCG Matrix for key Companies
  • Figure 15. Zoetis (United States) Revenue, Net Income and Gross profit
  • Figure 16. Zoetis (United States) Revenue: by Geography 2020
  • Figure 17. Merck Animal Health (United States) Revenue, Net Income and Gross profit
  • Figure 18. Merck Animal Health (United States) Revenue: by Geography 2020
  • Figure 19. Elanco (United States) Revenue, Net Income and Gross profit
  • Figure 20. Elanco (United States) Revenue: by Geography 2020
  • Figure 21. Boehringer Ingelheim (Germany) Revenue, Net Income and Gross profit
  • Figure 22. Boehringer Ingelheim (Germany) Revenue: by Geography 2020
  • Figure 23. Ceva (France) Revenue, Net Income and Gross profit
  • Figure 24. Ceva (France) Revenue: by Geography 2020
  • Figure 25. Phibro Animal Health (United States) Revenue, Net Income and Gross profit
  • Figure 26. Phibro Animal Health (United States) Revenue: by Geography 2020
  • Figure 27. Virbac (France) Revenue, Net Income and Gross profit
  • Figure 28. Virbac (France) Revenue: by Geography 2020
  • Figure 29. Vetoquinol (France) Revenue, Net Income and Gross profit
  • Figure 30. Vetoquinol (France) Revenue: by Geography 2020
  • Figure 31. Hester (India) Revenue, Net Income and Gross profit
  • Figure 32. Hester (India) Revenue: by Geography 2020
  • Figure 33. Hipra (Spain) Revenue, Net Income and Gross profit
  • Figure 34. Hipra (Spain) Revenue: by Geography 2020
  • Figure 35. IDT Biologika (Germany) Revenue, Net Income and Gross profit
  • Figure 36. IDT Biologika (Germany) Revenue: by Geography 2020
  • Figure 37. China Animal Husbandry (China) Revenue, Net Income and Gross profit
  • Figure 38. China Animal Husbandry (China) Revenue: by Geography 2020
  • Figure 39. Biogenesis Bago (Argentina) Revenue, Net Income and Gross profit
  • Figure 40. Biogenesis Bago (Argentina) Revenue: by Geography 2020
  • Figure 41. Tianjin Ringpu (China) Revenue, Net Income and Gross profit
  • Figure 42. Tianjin Ringpu (China) Revenue: by Geography 2020
  • Figure 43. Jinyu Bio-technology (China) Revenue, Net Income and Gross profit
  • Figure 44. Jinyu Bio-technology (China) Revenue: by Geography 2020
  • Figure 45. Global Animal Vaccine: by Type USD Million (2021-2026)
  • Figure 46. Global Animal Vaccine: by Application USD Million (2021-2026)
  • Figure 47. South America Animal Vaccine Share (%), by Country
  • Figure 48. Asia Pacific Animal Vaccine Share (%), by Country
  • Figure 49. Europe Animal Vaccine Share (%), by Country
  • Figure 50. MEA Animal Vaccine Share (%), by Country
  • Figure 51. North America Animal Vaccine Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Zoetis (United States)
  • Merck Animal Health (United States)
  • Elanco (United States)
  • Boehringer Ingelheim (Germany)
  • Ceva (France)
  • Phibro Animal Health (United States)
  • Virbac (France)
  • Vetoquinol (France)
  • Hester (India)
  • Hipra (Spain)
  • IDT Biologika (Germany)
  • China Animal Husbandry (China)
  • Biogenesis Bago (Argentina)
  • Tianjin Ringpu (China)
  • Jinyu Bio-technology (China)
Select User Access Type

Key Highlights of Report


Nov 2021 244 Pages 69 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Animal Vaccine Market Quantitative research analysis
Global Animal Vaccine Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The Animal Vaccine market is expected to see a CAGR of % during projected year 2020 to 2026.
Top performing companies in the Global Animal Vaccine market are Zoetis (United States), Merck Animal Health (United States), Elanco (United States), Boehringer Ingelheim (Germany), Ceva (France), Phibro Animal Health (United States), Virbac (France), Vetoquinol (France), Hester (India), Hipra (Spain), IDT Biologika (Germany), China Animal Husbandry (China), Biogenesis Bago (Argentina), Tianjin Ringpu (China) and Jinyu Bio-technology (China), to name a few.
"continuously increasing product portfolio " is seen as one of major influencing trends for Animal Vaccine Market during projected period 2020-2026.

Know More About Global Animal Vaccine Market Report?

Have a Query? Click Here

Other Related Reports

Animal Model Comprehensive Study by Type (Rats, Mice, Rabbits, Dogs, Pigs, Cats, Others), Application (Physiology, Toxicology, Cancer Research, Neurological Research, Biomedical Research, Genetic Res...
$ 3750
Stem Cell Banking Comprehensive Study by Type (Umbilical Cord Blood Stem Cell, Embryonic Stem Cell, Adult Stem Cell, Others), Application (Personalized Banking Applications, Research Applications {Di...
$ 3750
Hemostasis and Tissue Sealing Agents Comprehensive Study by Type (Topical Hemostats (Mechanical Hemostats, Active Hemostats, Flowable Hemostats, Fibrin Sealants, and Topical Thrombin Products), Adhes...
$ 3750
Direct-Fed Microbials Comprehensive Study by Type (Lactic Acid Bacteria,, Bacillus subtilis, Yeast, Others), Application (Poultry, Swine, Ruminants, Aquatic Animals, Others), Form (Dry, Liquid), Dist...
$ 3450
Microscopy Comprehensive Study by Type (Microscopes (Optical Microscopes, Electron Microscopes, and Scanning Probe Microscopes), Software, Accessories), Application (Semiconductors, Life Sciences, Ma...
$ 3650
Immunochemicals Comprehensive Study by Type (Custom monoclonal antibodies, Custom polyclonal antibodies, Custom AB fragments, Catalogue antibodies, Others), Application (Healthcare, Environmental Sci...
$ 3750